CMS Should Rethink Latest Lab Cut, Revaluation Proposals, Industry Says
This article was originally published in The Gray Sheet
Executive Summary
CMS’ plans to cut reimbursement to independent labs by 26 percent next year, largely based on a policy to cap at outpatient rates, and to perform a wholesale review and revision of physician fee schedule laboratory payments in the longer term were met with resistance by ACLA, AdvaMed and other industry stakeholders.